⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib

Official Title: Randomized Phase II Trial of Sorafenib and Erlotinib or Sorafenib Alone in Patients With Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib

Study ID: NCT00609804

Interventions

Sorafenib
Erlotinib

Study Description

Brief Summary: This is a randomized, open-label, multi-center, Phase II study of treatment of patients with advanced NSCLC who have progressed on erlotinib with the combination of sorafenib and erlotinib or sorafenib alone.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Florida Cancer Specialists, Fort Myers, Florida, United States

Northeast Georgia Medical Center, Gainesville, Georgia, United States

Wellstar Cancer Research, Marietta, Georgia, United States

Providence Medical Group, Terre Haute, Indiana, United States

Norton Cancer Institute, Louisville, Kentucky, United States

Hematology Oncology Clinic, LLP, Baton Rouge, Louisiana, United States

Center for Cancer and Blood Disorders, Bethesda, Maryland, United States

National Capital Clinical Research Consortium, Bethesda, Maryland, United States

Jackson Oncology Associates, Jackson, Mississippi, United States

St. Louis Cancer Care, Chesterfield, Missouri, United States

Research Medical Center, Kansas City, Missouri, United States

Nebraska Methodist Cancer Center, Omaha, Nebraska, United States

Hematology-Oncology Associates of Northern NJ, Morristown, New Jersey, United States

Associates in Hematology Oncology, Chattanooga, Tennessee, United States

Chattanooga Oncology Hematology Associates, Chattanooga, Tennessee, United States

Tennessee Oncology, PLLC, Nashville, Tennessee, United States

Contact Details

Name: David Spigel, M.D.

Affiliation: SCRI Development Innovations, LLC

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: